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Abstract
Background: Clostridium tetani and Clostridium perfringens are among the medically important
clostridial pathogens causing diseases in man and animals. Several homologous open reading frames
(ORFs) have been identified in the genomes of the two pathogens by comparative genomic analysis.
We tested a likelihood of extensive sharing of common epitopes between homologous proteins of
these two medically important pathogens and the possibility of cross-protection using active
immunization.
Results: Eight predominant cross-reactive spots were identified by mass spectrometry and had
hits in the C. tetani E88 proteome with significant MOWSE scores. Most of the cross-reactive
proteins of C. tetani shared 65–78% sequence similarity with their closest homologues in C.
perfringens ATCC13124. Electron transfer flavoprotein beta-subunit (CT3) was the most abundant
protein (43.3%), followed by methylaspartate ammonia-lyase (36.8%) and 2-phosphoglycerate
dehydratase (35.6%). All the proteins were predicted to be cytoplasmic by PSORT protein
localization algorithm. Active immunization with C. perfringens whole cells elicited cross-protective
immunity against C. tetani infection in a mouse model.
Conclusion: Most of the dominant cross-reactive proteins of C. tetani belonged to the cluster of
orthologous group (COG) functional category, either of posttranslational modification, protein
turnover, and chaperones (O) or energy production and conversion (C). The homologs of the
identified proteins have been shown to play role in pathogenesis in other Gram-positive pathogenic
bacteria. Our findings provide basis for the search of potential vaccine candidates with broader
coverage, encompassing more than one pathogenic clostridial species.
Background
Clostridium tetani and Clostridium perfringens are among
the medically important clostridial pathogens causing dis-
eases in man and animals. Clostridium tetani is an anaero-
bic pathogen possessing a wide arsenal of virulence
factors and is the causative agent for tetanus disease. Teta-
nus disease, and in particular maternal and neonatal teta-
nus, is still an important cause of death due to insufficient
immunization [1,2]. Neonatal tetanus is considered
endemic to 90 developing countries and resulted in
248000 deaths in 1997 (World Health Organization;
http://www.who.int/vaccine-diseases/NeonatalTeta
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nus.shtml). Tetanus continues to cause ~250,000 deaths
worldwide each year, predominantly in low- and middle-
income countries. Tetanus is characterized by muscle
rigidity and painful muscle spasms caused by tetanus
toxin's blockade of inhibitory neurons that normally
oppose and modulate the action of excitatory motor neu-
rons.
On the other hand, C. perfringens is an obligate anaerobic
rod shaped bacterium commonly found in the gastroin-
testinal tracts of both animals and humans and widely
distributed in soil and sewage. It is an etiological agent,
causing several diseases in humans and animals; the
former includes gas gangrene, food poisoning, necrotiz-
ing enterocolitis of infants and enteritis necroticans [3-5].
The incidence of disease ranged from 1% or less of
wounded personnel during World War II to 10% of
wounded personnel during World War I. Hundreds of
thousands of soldiers died of gas gangrene as a result of
battlefield injuries, and C. perfringens was widely recog-
nised as being the most important causal organism of the
disease.
Many vaccines have been developed from live attenuated
forms of bacterial pathogens or from killed bacterial cells
[6]. However, an increased awareness of the potential for
transient side effects following vaccination has prompted
an increased emphasis on the use of subunit vaccines.
Despite the fact that a high-level antibody response does
not always correlate with protection, presence of antibod-
ies in a host surviving infection can offer clues towards
identification of protective antigens of a pathogen.
Several striking findings have emerged from the complete
genome sequencing data of these clostridial pathogens
[7,8]. Many homologous ORFs have been identified in the
genomes of C. tetani and C. perfringens by comparative
genomic analysis of the two genomes. Of the total 2372
ORFs observed in C. tetani E88, 1705 ORFs had a close
homologue in C. perfringens genome showing significant
sequence similarity [8]. This suggested a likelihood of
extensive sharing of common epitopes between homolo-
gous proteins of these two medically important patho-
gens. To examine this hypothesis, we probed the total
cellular proteins of C. tetani with antisera raised against
whole cells of C. perfringens ATCC13124. Cross-reactive
proteins have been identified and protection against chal-
lenge with C. tetani to animals actively immunized with C.
perfringens whole cell has been reported.
Results and discussion
Immunization against heat killed C. perfringens organisms
produced a high titer of antibodies (1:10000) recognizing
several proteins as revealed by Western blot analysis of
one dimensional SDS-PAGE separated proteins from C.
perfringens whole cell lysate (data not shown). In contrast
serum obtained from sham immunized animals was
devoid of such antibody.
Mouse C. perfringens whole cell (CPWC) polyclonal anti-
body reacted with several proteins of C. tetani as revealed
by 2-DE blot (Fig.1 in additional file 3). C. tetani whole
cell lysate (CTWC) was also probed with serum from
sham-immunized animals; no spots were detected (data
not shown). Eight predominant cross-reactive spots were
identified in the parallel-run Coomassie-stained gels by
use of the coordinates of molecular weight markers and pI
values on linear IPG strips on the 2DE gel. The spots were
excised and identified by mass spectrometry (Table 1 in
additional file 1). All the spots had a match in C. tetani
E88 proteome with significant MOWSE score using the
Protein Prospector search tool and the same hits were
observed using Mascot search engine with significant pro-
tein score. Eight to nineteen peptides were identified in
the peptide mass fingerprint and the % coverage for the
identified proteins ranged between 33 – 55% except for
spot CT7 which remained a little low (27%). On most
occasions there was a good correlation between the
observed and theoretical molecular mass and pI values.
The results suggest unambiguous identification of cross-
reactive proteins of C. tetani by peptide mass fingerprint-
ing. Extensive epitope mapping would be required to
identify precise antibody recognition regions of the cross-
reactive proteins.
The cross-reactive proteins of C. tetani shared 65 – 78%
sequence similarity with their closest homologues in C.
perfringens  ATCC13124, except for methylaspartate
ammonialyase (spot CT7) which showed 30% sequence
identity (Table 1 in additional file1). Most of the domi-
nant cross-reactive proteins belonged to the COG func-
tional category, either of posttranslational modification,
protein turnover, and chaperones (O) or energy produc-
tion and conversion (C) (Table 1 in additional file 1).
Electron transfer flavoprotein beta-subunit (CT3) was the
most abundant protein (43.3%) followed by methyl-
aspartate ammonia-lyase (36.8%) and 2-phosphoglycer-
ate dehydratase (35.6%). All the proteins were predicted
to be cytoplasmic by PSORT protein localization algo-
rithm.
Spot CT1 belonged to the family of Hsp70 chaperones
that are known to assist folding of many proteins. It is
interesting to note that the hsp70 has been shown to play
an important role in imparting adaptive features which
allow Helicobacter pylori to survive and establish chronic
gastroduodenal infections [11-13]. The two cytoplasmic
heat shock proteins (HSPs), DnaK and GroEL, have been
shown to be among the major targets of the humoral
immune response to a Chlamydia trachomatis infectionBMC Microbiology 2008, 8:194 http://www.biomedcentral.com/1471-2180/8/194
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[14]. Antibodies to C. tetani DnaK and groEL (Table 1 in
additional file 1) may have an impact on other infections
because HSPs are highly conserved in evolution. Curi-
ously, GroEL has also been implicated in the adherence of
C. difficile and found to be predominantly cytoplasmic
and membrane bound, consistent with surface localiza-
tion of this protein in clostridia [15]. The 60 kDa form of
chaperonin (spot CT2) is also the immunodominant anti-
gen of patients with Legionnaire's disease, and is thought
to play a role in the protection of the Legionella bacteria
from oxygen radicals within macrophages [16]. This
hypothesis is based on the finding that the cpn60 gene is
up-regulated in response to hydrogen peroxide, a source
of oxygen radicals. A similar role for protection against
oxygen radicals for these clostridial species needs to be
explored as generation of anaerobic environment for pro-
liferation of anaerobic clostridial pathogens like C. perf-
ringens and C. tetani is the first step in colonization of the
bacteria.
Two cross-reactive C. tetani proteins (spot CT6 and CT7)
were identified as methylaspartate ammonialyase having
ClpB proteins as a homolog in the C. perfringens
ATCC13124 proteome. Clp amino terminal domain is
found in one or two copies at the amino terminus of ClpA
and ClpB proteins from bacteria and eukaryotes. The
function of these domains is uncertain but they have been
postulated to form a protein binding site. The proteins are
thought to be subunits of ATP-dependent proteases which
act as chaperones to target the proteases to substrates
[17,18]. These proteins are part of the complex program
that bacteria undergo in order to survive adverse environ-
mental conditions. Interestingly, the proteins under the
control of the regulatory two-component system VirR/
VirS in C. perfringens have been analyzed by using two-
dimensional gel electrophoresis of the culture superna-
tant from the wild type and the virR mutant. Based on
MALDI-TOF mass spectrometry, seven positively regu-
lated proteins and eight negatively regulated proteins
were identified that included ClpB protein [19].
Enolase (spot CT5) and butyrate kinase (spot CT9) have
been observed as cross-reactive protein of C. tetani (Table
1 in additional file 1, Fig. 1). Streptococcal enolase has
been implicated in GAS adherence to and invasion of
human pharyngeal cells and is a highly immunogenic
autoantigen with a possible role in the initiation of post-
streptococcal sequelae [20]. Curiously, butyrate kinase
pathway among butyrate-producing bacteria from the
human colon has been shown to have restricted distribu-
tion. Butyryl-CoA:acetate CoA-transferase activity was
detected in all 38 strains examined, suggesting that it,
rather than butyrate kinase, provides the dominant route
for butyrate formation in the human colonic ecosystem
that contains a constantly high concentration of acetate
[21].
Survival of animals that were immunized against heat
killed C. perfringens organism and were challenged with C.
tetani viable cells has been shown in table 2 in additional
file 2. Except for the lowest dose of challenge (102 cfu),
most of the deaths were recorded within 30 h of challenge
and survival did not decrease further during the remaining
5 days of study. In most of the cases, paralysis of limbs
preceded death. Immunization with C. perfringens did not
result in protection against a direct tetanus toxin challenge
when tested with 1, 3 and 5 MLD of crude tetanus toxin
preparations, indicating a non-tetanus-toxin based proc-
ess of protection, inhibiting colonization of the bacte-
rium. We did not observe any binding of antibodies from
polyclonal serum with tetanus toxin when tested on a
western blot using 10 μg of recombinant TeNT. The com-
plete ORF of TeNT was previously cloned and expressed in
pQE30 vector and the recombinant protein purified using
Ni-NTA column (unpublished results).
Ability of the mice C. perfringens whole cell (CPWC) pol-
yclonal antibody to bind on the surface of the C. perfrin-
gens  and C. tetani cells was tested using anti-IgG FITC
conjugate as described in the methods. A bright yellow
green fluorescence was observed, with whole cells of both
C. perfringens and C. tetani (Additional file 4) indicating a
surface binding of the mouse polyclonal antibody, raised
against heat-killed C. perfringens cells. The corresponding
slide where un-immunised serum was used, did not
exhibit a detectable fluorescence.
Despite a predicted cytoplasmic localization of the identi-
fied proteins, their exact location needs to be experimen-
tally verified. As immuno-fluorescence microscopy
indicated binding of the polyclonal CPWC antibody to
the surface of both C. perfringens and C. tetani (Addi-
tional file 3), we do not rule out the possibility of at least
some of the cross-reactive proteins identified in the
present investigation, to be actually surface localized. This
could be a possible explanation for the cross-protection
observed against C. tetani cells. However, other low abun-
dance cross-reactive proteins not identified here, remains
another possibility. A more detailed study, using mono-
clonal antibodies and identification of additional cross-
reactive proteins is required to ascertain the exact basis of
the cross-protection. It is also possible that some antibod-
ies, presumably protective in nature and recognize other
proteins, has not been detected in our study. The pro-
teomic approach used in this study identified only cross-
reactive proteins shared between C. perfringens and C.
tetani. It remains possible that other (non protein) anti-
gens are also shared between these two bacteria and that
those shared antigens contribute to the protectionBMC Microbiology 2008, 8:194 http://www.biomedcentral.com/1471-2180/8/194
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Two dimensional gel electrophoresis (2-DE) profile of Clostridium tetani whole cell lysate (A) and immunoblot developed  against mice anti-C. perfringens (whole cell) serum (B) Figure 1
Two dimensional gel electrophoresis (2-DE) profile of Clostridium tetani whole cell lysate (A) and immunoblot 
developed against mice anti-C. perfringens (whole cell) serum (B). Spots identified are indicated by arrows.BMC Microbiology 2008, 8:194 http://www.biomedcentral.com/1471-2180/8/194
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observed when C. perfringens-immunized mice are chal-
lenged with C. tetani.
Only little is known about protein secretory systems in
clostridia. In a previous study, the culture supernatant of
C. perfringens at the late exponential growth phase was
shown to contain intracellular proteins that had no puta-
tive signal sequences, such as ribokinase, β-hydroxybu-
tyryl-coenzyme A dehydrogenase, fructosebisphosphate
aldolase, and elongation factor G [19]. In other studies
also, a significant number of cytoplasmic proteins have
been identified as cell-wall associated proteins/immuno-
gens [22,23]. The normally cytoplasmic chaperonins
DnaK and GroEL have been identified as immunoreactive
surface antigens of S. pyogenes [22]. In another report, 21
predicted cytoplasmic proteins were detected on the sur-
face of S. pyogenes [23]. Though authors did not address
the mechanism by which proteins localize to the cell sur-
face, several lines of evidence suggested that no measura-
ble lysis occurred during the treatment of the cells with
trypsin. Since a signal peptide and LPXTG motif were
absent, it was suggested that these proteins are either pas-
sively released during autolysis or that an alternative
secretory pathway may exist for many secreted GAS pro-
teins.
Conclusion
Most of the dominant cross-reactive proteins of C. tetani
belonged to the COG functional category, either of post-
translational modification, protein turnover, and chaper-
ones (O) or energy production and conversion (C). The
homologs of the identified proteins have been shown to
play a role in pathogenesis in other Gram-positive patho-
genic bacteria. Our findings provide basis for the search of
potential vaccine candidates with broader coverage,
encompassing more than one pathogenic clostridial spe-
cies. They also generate curiosity to explore any correla-
tion of these results with the general immunity and
success of immunization programmes against C. tetani; in
developed countries, tetanus is little more than a medical
curiosity. It has to be borne in mind that the primary hab-
itat of C. tetani is soil and unlike C. perfringens, is not com-
monly found in the gastrointestinal tracts of animals and
humans. The cross-protective nature of C. perfringens
could be a possible reason as to why neonatal tetanus is
more prevalent than tetanus disease in adults having
extensive colonization of and exposure to C. perfringens.
Methods
Bacterial strains and growth conditions
The clinical strain of Clostridium tetani was obtained from
Christian Medical College, Vellore, India. The strain
exhibited 100% sequence identity with C. tetani strain E88
at 16S rDNA level. Clostridium perfringens ATCC13124 was
obtained from Becton Dickinson India Pvt. Ltd., India.
The clostridial isolates were cultivated anaerobically at
37°C in trypticase peptone yeast-extract glucose (TPYG)
broth containing pancreatic digest of casein, 50 g; pep-
tone, 5 g; yeast extract, 20 g; glucose, 4 g; sodium thiogly-
collate, 1 g; cycloserine, 250 mg; sulphamethoxazole, 76
mg and trimethoprim, 4 mg per litre.
Immunization and protection studies
Animal experiments were approved by the institutional
Animal Ethical Committee at DRDE, Gwalior. Four-week-
old female BALB/c mice were actively immunized against
heat-killed vegetative cells of C. perfringens in a four week
immunization schedule. Cells were grown in TPYG broth
at 37°C, harvested in the exponential phase (OD600 nm
0.8–1.0) and washed with phosphate buffer saline (PBS).
The number of bacteria in the final suspension was deter-
mined by plating 10-fold serial dilutions onto SPS agar
(Difco, USA) plates containing tryptone, 15 g; yeast
extract, 10 g; ferric citrate, 0.5 g; sodium sulfite, 0.5 g;
sodium thioglycollate, 0.1 g; polysorbate 80, 0.05 g; sul-
fadiazine, 0.12 g; polymyxin B sulfate, 0.01 g; agar, 15 g
per litre. Heat inactivation was accomplished in a water
bath at 60°C for 30 min. No live bacteria were detected
after this suspension was plated onto agar plates. Cells
were injected intraperitoneally using Freund's complete
adjuvant (Sigma Aldrich, India) for the first immuniza-
tion and Freund's incomplete adjuvant for booster immu-
nizations. On day 1 and 7, 102 cfu (100 μl cell suspension
in PBS and 100 μl adjuvant) was injected in each mouse
while on day 14 and 27 the dose was increased to 104
CFU. One week after administration of the last booster, 10
animals were anesthetized by halothane inhalation, and
blood specimen (500 μl) was obtained from each by
means of retroorbital puncture. Serum from these speci-
mens was pooled and was used to verify specific antibody
production by Western blot analysis. Sham-immunized
animals received an equal volume of adjuvant alone in a
parallel, same immunization schedule and serum was col-
lected after 5 weeks.
For protection studies, four-week-old female BALB/c mice
were similarly immunized with heat killed vegetative cells
of C. perfringens in a four week immunization schedule as
described above. On day 37, groups of immunized (with
CPWC) and sham-immunized animals (n = 12) were
challenged intra-peritonealy with different inocula of
freshly grown C. tetani cells (1.2 × 102, 1.2 × 104, 1.2 ×
106, and 1.2 × 108 cfu). Death, as well as paralytic symp-
toms were recorded every 6 hr up to day 2 and every 12
hours for seven days. Animals that survived for the entire
7-days were considered survivors.
The culture supernatant from C. tetani was titrated for esti-
mation of minimum lethal dose (MLD) by serial two-fold
dilutions made in gelatin diluent. One half milliliter ofBMC Microbiology 2008, 8:194 http://www.biomedcentral.com/1471-2180/8/194
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each dilution was inoculated i.p. into each of six 20 gram
mice. The mice were observed for four days and the flaccid
paralysis and deaths were recorded. Mice immunized with
heat killed C. perfringens, were challenged with 1, 3, and 5
MLD (n = 6) of crude tetanus toxin and observed for death
and paralysis. Sham-immunised mice (n = 6) were also
given equivalent doses of tetanus toxin i.p.
Two dimensional gel electrophoresis (2-DE)
Twenty milliliter of culture was harvested in the exponen-
tial growth phase (OD600 nm~0.8) and washed in 50 mM
Tris/HCl, pH 7.5. The cells were resuspended in the same
buffer supplemented with protease inhibitor (Protease
inhibitor cocktail, Sigma). Cell lysis was performed by
sonication and the un-disrupted cells were removed by
centrifugation (6000 × g; 15 min; 4°C). In order to
improve focusing of proteins the lysates (500 microgram)
were purified using 2D-cleanup kit (Bio-Rad) and the pro-
tein pellet was finally resuspended in 250 μl of sample
rehydration buffer (8 M urea, 2% w/v CHAPS, 15 mM
DTT and 0.5% v/v IPG buffer pH 3–10).
Total protein concentration was determined according to
the method of Bradford [9] using Quick Start Bradford
Protein Assay kit (Bio-Rad, USA) as per manufacturer's
instructions. The protein concentration was calculated
using bovine serum albumin (BSA) as standard.
The isoelectric focusing was performed using immobi-
lized pH gradient (IPG) strips (Bio-Rad, USA). IPG strips
with a pH range from 5–8 were used for all the experi-
ments. For the first dimension 250 μg of protein samples
in 125 μl of rehydration solution was used to rehydrate
IPG strip (7 cm, pH 5–8). The IPG strips were rehydrated
overnight and then the proteins were focused for 8000
VHr at 20°C under mineral oil. After focusing, the strips
were incubated for 10 min, in 2 ml of equilibrium buffer
I (6 M urea, 30% w/v glycerol, 2% w/v SDS and 1% w/v
DTT in 50 mM Tris/HCl buffer, pH 8.8) followed by equi-
librium buffer II (6 M urea, 30% w/v glycerol, 2% w/v SDS
and 4% w/v iodoacetamide in 50 mM Tris/HCl buffer, pH
8.8). After the equilibration steps the strips were trans-
ferred to 12% SDS-PAGE for the second dimension by the
method of Blackshear [10]. Protein spots were visualized
by staining with Commassie Brilliant Blue G-250. Gel
images were capture by GS800 densitometer (Bio-Rad,
USA). Relative abundance of spots was determined by PD
Quest software (Bio-Rad, USA).
Two independent cell preparations were pooled together
for running the 2DE gel and obtaining the corresponding
immunoblot. Replicate gels were generated from two such
independent experiments, of which one representative gel
has been shown.
Immunoblotting
For immunoblotting, the one dimensional or 2-DE sepa-
rated proteins were transferred electrophoretically to
nitrocellulose membrane (Bio-Rad, Hercules, CA) and
then blocked with 5% skim milk in PBS (pH 7.2). Hyper-
immune serum from mice raised against C. perfringens
whole cell (CPWC) was used at 1:4000 dilutions in block-
ing buffer. Goat anti-mouse HRP conjugate was used as
secondary antibody and blots were developed using the
Immuno-Blot HRP assay kit (Bio-Rad, USA) as per manu-
facturer's instructions.
Immunofluorescence Microscopy
One milliliter of culture was harvested in the exponential
growth phase (OD600 nm~0.8), washed in phosphate
buffer saline (PBS), pH 7.2, and resuspended in 1 ml of
same buffer. Twenty microlitre of cells were air dried on 4
mm wells of printed slides (Flow Lab, USA) and fixed with
methanol for 5 min. C. perfringens ATCC13124 and C.
tetani cells were added to duplicate wells on two inde-
pendent slides. Each spot was washed twice with PBS and
blocked with 0.5% gelatin in PBS (PBSG) for 30 min at
37°C. To one slide, serum from sham-immunized mice
(40 μl) was added at 1:40 dilution in PBSG and to the
other slide mouse anti-C. perfringens serum was similarly
added. Slides were incubated in humid chamber at 37°C
for 1 hr and then washed 4 times with PBS. Forty microli-
tre of goat anti-mouse IgG fluorescein isothiocyanate
(FITC) conjugate (Dako, Denmark) was added (1:20
diluted in PBSG) to each well and incubated in dark,
moist chamber for 30 min at 37°C. Slides were washed
with 4 changes of PBS and observed under a fluorescence
microscope (Leica, Germany).
Identification of protein spots by mass spectrometry
Protein spots were excised with the help of thin-walled
PCR tubes (200 μl) appropriately cut at the bottom with
the help of fresh surgical scalpel blade. Care was taken not
to contaminate the spots from adjoining proteins or with
skin keratin. The gel spots were washed with proteomic
grade de-ionized water and identified by mass spectrome-
try by the commercial services provided by Dominion
Pharmakine, Spain. The gel piece containing the protein
was destained, reduced/alkylated and digested using the
Montage In-Gel Digest Kit (Millipore) following the kit's
instructions.
Analysis was performed using the Voyayer-DE PRO
BioSpectrometry workstation from Applied Biosystems.
Spectrum was obtained in the mass range of 500–4000 Da
and calibrated using a calibration mixture containing
angiotensin I, Substance P, ACTH (1–17), ACTH (18–39)
and somatostain (28). Peptides masses of the unknown
proteins were sent to two different peptide mass finger-
printing databases, Mascot from Matrix Science http://BMC Microbiology 2008, 8:194 http://www.biomedcentral.com/1471-2180/8/194
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www.matrixscience.com and MS-Fit from Protein Pros-
pector http://prospector.ucsf.edu and/or Aldente http://
www.expasy.ch/tools/aldente. There were 3292813
entries in the Mascot database at the time of search. Search
parameters were as follow: maximum allowed peptide
mass error of 100 ppm, consideration of one incomplete
cleavage per peptide and at least 4 peptides identified.
Protein localization prediction was performed by the
online tool PSORT at http://www.expasy.ch/.
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Replicate 2DE gels stained with coomassie brilliant blue [A (i) and 
(ii)] and corresponding immunoblots [B (i) and (ii)] developed 
against mice anti-C. perfringens (whole cell) serum.




C. perfringens(A) and C. tetani(B) cells showing immuno-fluores-
cence under fluorescent microscope(magnification-100 ×). Cells were 
allowed to bind with mouse polyclonal anti-C. perfringens (whole cell) 
serum and binding was revealed by goat anti-mouse IgG-FITC conjugate. 
C, Control image of C. perfringens cells which were allowed to bind with 
sham-immunized serum followed by addition of revealing anti-mouse 
IgG-FITC conjugate.
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